CIS
IART icon

Custom Index Systems’s Integra LifeSciences IART Stock Holding History

Custom Index Systems’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.3K Buy
+2,413
New +$33.7K 0.02% 400

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Custom Index Systems's IART Position: Q2 2026 in Review

Custom Index Systems opened a new position in Integra LifeSciences (IART) in Q2 2026: 2,413 shares worth $43.3K. The stake represents 0.02% of the portfolio and ranks #400 among its holdings.

212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Custom Index Systems held 2,413 shares of Integra LifeSciences worth $43.3K as of Q2 2026.
  • Integra LifeSciences was a new Custom Index Systems position in Q2 2026.
  • Integra LifeSciences made up 0.02% of Custom Index Systems's portfolio in Q2 2026, its #400 holding.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Custom Index Systems's 13F filing for Q2 2026, filed 14 Aug 2026.